We further observed that correcting the augmented H4B deficiency to restore eNOS function, with oral treatment of folic acid (FA) that restores the expression and activity of the H4B salvage enzyme dihydrofolate reductase (DHFR) in the endothelium, eliminated the incidence of AAA [18]. This evidence concerns the gene NOS3 and triple-A syndrome.